Filtered By:
Source: Stroke
Management: Healthcare Costs

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke: Current Evidence Clinical Sciences
Conclusions— Our analysis supports earlier economic evaluations that r-tPA is a cost-effective method to treat stroke. Appropriate use of r-tPA should be prioritized nationally.
Source: Stroke - September 22, 2014 Category: Neurology Authors: Boudreau, D. M., Guzauskas, G. F., Chen, E., Lalla, D., Tayama, D., Fagan, S. C., Veenstra, D. L. Tags: Emergency treatment of Stroke, Thrombolysis Clinical Sciences Source Type: research

Cost-Effectiveness of Thrombolysis Within 4.5 Hours of Acute Ischemic Stroke: Experience From Australian Stroke Center Clinical Sciences
Conclusions— Intravenous tPA within 4.5 hours represents a cost-effective intervention for acute ischemic stroke.
Source: Stroke - July 22, 2013 Category: Neurology Authors: Tan Tanny, S. P., Busija, L., Liew, D., Teo, S., Davis, S. M., Yan, B. Tags: Thrombolysis Clinical Sciences Source Type: research